SCHEMBL14068110

SCHEMBL14068110

CC(C)CC(C(=O)Oc1c(F)c(F)c(F)c(F)c1F)C1OC(C)(C)OC1=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7391620 1.00 L3MBTL1 (0.32) L3MBTL1
SCHEMBL2245759 1.00 L3MBTL1 (0.32) L3MBTL1
SCHEMBL1610462 1.00 L3MBTL1 (0.32) L3MBTL1
SCHEMBL1609717 1.00 L3MBTL1 (0.32) L3MBTL1
SCHEMBL11988498 0.79 CTSK (0.30)
SCHEMBL11988497 0.79 CTSK (0.30)
SCHEMBL2247539 0.78 L3MBTL1 (0.43) L3MBTL1
SCHEMBL1610132 0.78 L3MBTL1 (0.43) L3MBTL1
SCHEMBL8887738 0.78 L3MBTL1 (0.43) L3MBTL1
SCHEMBL3872212 0.78 L3MBTL1 (0.43) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008104755-A1 SUCCINATE DERIVATIVES AND THEIR THERAPEUTIC USE SERENTIS LIMITED (GB) 2008-09-04 WO disclosed